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Original ArticleIncidence of Postoperative Hematomas Requiring Surgical Treatment in Neurosurgery: ARetrospective Observational StudyKadri Lillemäe1,2, Johanna Annika Järviö1, Marja Kaarina Silvasti-Lundell1,2, Jussi Juha-Pekka Antinheimo1,3,
Juha Antero Hernesniemi1,3, Tomi Tapio Niemi1,2-OBJECTIVE: We aimed to characterize the occurrence of
postoperative hematoma (POH) after neurosurgery overall
and according to procedure type and describe the preva-
lence of possible confounders.
-METHODS: Patient data between 2010 and 2012 at the
Department of Neurosurgery in Helsinki University Hospital
were retrospectively analyzed. A data search was per-
formed according to the type of surgery including crani-
otomies; shunt procedures, spine surgery, and spinal cord
stimulator implantation. We analyzed basic preoperative
characteristics, as well as data about the initial interven-
tion, perioperative period, revision operation and neuro-
logic recovery (after craniotomy only).
-RESULTS: The overall incidence of POH requiring reop-
eration was 0.6% (n [ 56/8783) to 0.6% (n [ 26/4726) after
craniotomy, 0% (n [ 0/928) after shunting procedure, 1.1%
(n [ 30/2870) after spine surgery, and 0% (n [ 0/259) after
implantation of a spinal cord stimulator. Craniotomy types
with higher POH incidence were decompressive craniec-
tomy (7.9%, n [ 7/89), cranioplasty (3.6%, n [ 4/112),
bypass surgery (1.7%, n [ 1/60), and epidural hematoma
evacuation (1.6%, n [ 1/64). After spinal surgery, POH was
observed in 1.1% of cervical and 2.1% of thoracolumbar
operations, whereas 46.7% were multilevel procedures.
64.3% of patients with POH and 84.6% of patients under-
going craniotomy had postoperative hypertension (systolic
blood pressure >160 mm Hg or lower if indicated). PoorKey words









DPOSEH: Delayed postoperative spinal epidural hematoma
DVT: Deep vein thrombosis
ICU: Intensive care unit
WORLD NEUROSURGERY 108: 491-497, DECEMBER 2017outcome (Glasgow Outcome Scale score 1e3), whereas
death at 6 months after craniotomy was detected in 40.9%
and 21.7%. respectively, of patients with POH who under-
went craniotomy.
-CONCLUSIONS: POH after neurosurgery was rare in this
series but was associated with poor outcome. Identifica-
tion of risk factors of bleeding, and avoiding them, if
possible, might decrease the incidence of POH.INTRODUCTIONn neurosurgery, postoperative hematoma (POH) is a rare, but
serious, complication that frequently leads to severe neuro-I logic impairment or death.1-3 POH rates after intracranial
procedures vary greatly, mainly because of the differences in
defining POH.2 It is not always possible to distinguish between
expected residual blood and small de novo hemorrhages, and
therefore, it has been concurred that the best definition for a
significant postoperative intracranial hemorrhage is a hematoma
clinically requiring surgical evacuation.2
Although some studies have reported POH after even up to 50%
of craniotomies in certain subgroups and based on routine
radiologic monitoring,2,4-6 the overall incidence of clinically
deteriorating POH range from 0.48% to 7.1%.1,2,7-21 In spinal
surgery, the incidence of epidural POH requiring surgical evacu-
ation is reportedly 0.1%e3%.3,22-34POH: Postoperative hematoma
VTE: Venous thromboembolism
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Male gender 10 (43.5) 17 (56.7) 27 (50.9)
Age (years), mean  standard
deviation
56  20.8 63  12.4 60  17.0
Body mass index (kg/cm2),
mean  standard deviation
25.7  4.2 27.4  4.0 26.6  4.2
Underlying diseases
Ischemic heart disease 2 (8.7) 3 (9.4) 5 (9.4)
Hypertension 9 (39.1) 14 (46.7) 23 (43.4)
Diabetes 3 (13.0) 5 (16.7) 8 (15.1)
Renal insufficiency 1 (4.3) 3 (9.4) 4 (7.5)
Liver insufficiency 0 (0) 1 (3.1) 1 (1.9)
Previous surgery NR 8 (26.7) NR
Emergency admission 13 (50.0) 4 (13.3) 17 (30.4)
Values are number (%) except where indicated otherwise.
NR, not reported.
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KADRI LILLEMÄE ET AL. POHS REQUIRING SURGICAL TREATMENT IN NEUROSURGERYBecause POH rates after neurosurgery vary greatly, the purpose
of this study was to determine the incidence of POH overall in
neurosurgery and according to procedure type. In addition, we
aimed to describe the prevalence of previously described possible




This was a retrospective observational study. All neurosurgical
patients at the Department of Neurosurgery in Helsinki University
Hospital, Helsinki, Finland with POH requiring surgical removal
between January 2010 and December 2012 were initially included
in the study. Patients were identified simultaneously by our elec-
tronic database and logbook with primary procedure code defined
as “postoperative hematoma.” Every patient’s electronic, as well as
paper, medical record was analyzed regarding preexisting
comorbidities, presence of previous surgeries on spine, preoper-
ative and perioperative medication, initial intervention, perioper-
ative period, revision operation, and neurologic recovery (this last
factor after craniotomy only). All cases that were incorrectly coded
in the electronic database or that showed an extracranial or no
hematoma during reoperation were excluded from final analysis.
Postoperative Care in the Study Center
All patients after craniotomies and cervical intradural spinal pro-
cedures are admitted to the neurosurgical intensive care unit (ICU)
until the first postoperative day (e.g., up to 24 hours). Patients
after spinal surgery are generally monitored for 2e6 hours also in
the same department. Postoperative imaging (computed tomog-
raphy or magnetic resonance imaging) is performed in selective
cases according to the surgeon’s decision and patients’ clinical
status. Local protocol on deep vein thrombosis (DVT) chemo-
prophylaxis is conservative. Mechanical prophylaxis (compression
stockings or intermittent pneumatic compression devices) is used
in all patients at risk for DVT. Pharmacologic prophylaxis with
low-molecular-weight heparin is started in high-risk patients
within 5e7 days postoperatively but usually not earlier than 3 days
after surgery. In complex cases, an individualized multidisci-
plinary approach, including an anesthesiologist, neurosurgeon,
and thrombosis specialist, is implemented.
Data Analysis
Data are given as mean with standard deviation and range.




During the 3-year period, 8783 procedures were performed,
including 4726 craniotomies, 2870 spinal surgeries, 928 shunting
procedures, and 259 implantations of spinal cord stimulators and
drug pumps. In 0.6% of procedures (56 cases of 8783: 26 after
craniotomies and 30 after spine operations), 53 patients had POH
leading to surgical removal. Four patients with POH after crani-
otomy (17.4%) and one after spinal procedure (3.3%) had POH492 www.SCIENCEDIRECT.com WORLD NEUmore than once, whereas 1 patient with serious traumatic brain
injury had 4 different procedures initially (decompressive hemi-
craniectomy on both sides that was later followed by cranioplasty
to both sides), after which POH developed every time. Thus, the
overall incidence of POH after craniotomies and spinal surgery
was 0.6% and 1.1%, respectively.
Baseline Characteristics
Patients’ general data are summarized in Table 1. Patients had an
average age of 60 years (range, 20e88) and 50.9% of patients were
male. The most common underlying diseases were hypertension
and diabetes, whereas about one third of patients for spinal
procedure had previously had an operation on the same part of
the spine.
Risk Factors
Of the possible risk factors described in earlier
studies,1-7,9-18,22-30,35-37 medications that have been reported to
interfere with coagulation cascade (nonsteroidal antiinflammatory
drugs, antiplatelet drugs, anticoagulants, selective serotonin reup-
take inhibitors, and antiepilepsy drugs) were being used preoper-
atively or postoperatively in 66.1% of cases, although in elective
cases (69.6%), they were discontinued before the primary inter-
vention according to our institutional recommendations. Hyper-
tension (systolic blood pressure>160 mmHg or lower if indicated)
during the early postoperative period was present in 64.3% of all
cases, whereas after craniotomies the rate was even higher (84.6%).
Of patients with postoperative hypertension who underwent
craniotomy, 81.8% received antihypertensive medications (labeta-
lol, clonidine, or other) in the ICU. The incidence of laboratory
disturbances possibly leading to hemorrhagic complicationsROSURGERY, http://dx.doi.org/10.1016/j.wneu.2017.09.007
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time value <70% (normal laboratory reference range, 70%e120%)
or any other coagulational defect) before the primary or hematoma
evacuation procedure was relatively low (14.5%, 17.3%, and 15.1%,
respectively), as well as perioperative hypothermia (body tempera-
ture <35C) during the initial intervention (25.0%).Data from Index Procedure
Mean American Society of Anesthesiologists score before primary
procedure was 3, whereas it was4 in 53.8% of craniotomies and in
6.7% of spinal procedures. Emergency or urgent surgery was pri-
marily performed in 30.4% of all cases and 50.0% of craniotomies.
In craniotomies (see Table 2), the procedure types with highest POH
incidence were decompressive craniectomy, with a rate of 7.9% of
cases (7 of 89); cranioplasty, with 3.6% (4 of 112); bypass surgery
with 1.7% (1 of 60); and epidural hematoma removal, with 1.6%
(1 of 64). No POH was reported after elective aneurysm,
arteriovenous malformation (AVM), dural fistula, intracerebral
hemorrhage removal, shunting procedures, or epilepsy surgery
during the study period. Of brain tumors, 60% (6 of 10) were
extirpated and 40% (4 of 10) were partially resected.
In spinal surgery, POH occurred after 0.4% of cervical (6 of
1455) and 2.1% of thoracolumbar (24 of 1143) operations. Of spinal
surgeries, 46.7% were multilevel procedures. All lesions were









Tumor surgery 1495 10 0.7
Aneurysm surgery 784 1 0.1
Nonruptured 419 0 0




Dural fistula surgery 13 0 0
Hematoma removal 1378 3 0.2
Subdural, acute 322 1 0.3
Subdural, chronic 803 1 0.1
Epidural 64 1 1.6
Intracerebral 189 0 0
Epilepsy surgery 127 0 0
Craniectomy 89 7 7.9
Cranioplasty 112 4 3.6
Bypass surgery 60 1 1.7
Other 595 0 0
Total 4726 26 0.6
WORLD NEUROSURGERY 108: 491-497, DECEMBER 2017Mean blood loss during craniotomies was 603 163 mL (range,
0e4000 mL) and during spinal procedures 192  65 mL (range,
0e1400 mL), whereas 42.3% of patients undergoing craniotomy
received red blood cell transfusion during index procedure.
Data from Hematoma Evacuation Procedure
Most POH evacuations were performed because of clinical dete-
rioration, although there were also a few POH that were detected
by radiologic imaging but because of large size or critical locali-
zation were evacuated based on the surgeon’s decision.
In spinal surgery, the localization of POH was epidural in most
cases (93.3%), whereas in craniotomies, it was epidural in 43.3%,
subdural in 20.0%, intracerebral in 16.7%, and mixed in 20.0% of
cases. After tumor surgery (total number 10), 50% were intra-
parenchymal, 20% epidural, 20% subdural, and 10% were mixed
hematomas. After craniectomies (total number 7), 71% were
epidural, 14% subdural, and 14% in mixed localizations. All
hematomas after cranioplasties (total number 4) were epidural.
Hematoma evacuation was performed between 0 hours (when
noticed immediately in the theater) and 20 days after the initial
operation, whereas the average time until reoperation after cra-
niotomies was 2.7 and 3.7 days after spine procedures. POH was
recognized and treated within 24 hours in 42.3% of cases after
craniotomies and in 26.6% after spinal procedures, whereas 53.3%
of spinal hematoma evacuation surgeries were performed more
than 3 days after the index procedure, so the incidence of delayed
postoperative spinal epidural hematoma (DPOSEH) in our series
was 0.6% (16 of 2870). The longest duration until recognition of
spinal POH and hematoma removal was 11 and 13 days,
respectively.
Outcome and Thrombotic Complications
Poor outcome (evaluated by Glasgow Outcome Scale score 1e3)
and death (Glasgow Outcome Scale score 1) at 6 months follow-up
period were detected, respectively, in 40.9% and 21.7% of patients
with POH after craniotomy. Because proper evaluation of clinical
outcome after spinal procedure retrospectively, based on medical
records, was problematic, we do not report it in this study.
One lower-extremity DVT, 1 thrombosis of the internal jugular
vein and venous sinuses, and 1 pulmonary embolism were
detected in this group of patients. The overall incidence of
thromboembolic complications in neurosurgical patients with
POH was therefore 5.7%, and because all 3 cases were after cra-
niotomies, the incidence in this subgroup was even higher
(13.0%).
DISCUSSION
POH after neurosurgery requiring surgical evacuation was an
uncommon complication in this series, occurring at an overall rate
of 0.6% (0.6% after craniotomies and 1.1% after spinal proced-
ures). There are not many systematic data about the overall rates
of POH after craniotomies; incidence figures vary depending on
definition, with rates of 0.48%e7.1% reported for postoperative
clinical deterioration after surgical evacuation1,2,7-21; and 10.
8%e50.0% based on routine radiologic monitoring, according to
a systematic review published in 2011.2 The investigators in that
particular review also included recommendations for clinicalwww.WORLDNEUROSURGERY.org 493
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already formed part of the daily practice and treatment protocols
of our neurosurgical unit. This factor certainly contributes to the
relatively low occurrence of POH after craniotomies in this series
compared with the average rates published in the literature so
far. Also, there might have been a few patients with clinically
important POH after craniotomies who nevertheless did not
undergo reoperation, but because of the retrospective design of
the study, we were unable to detect those patients and therefore
they might not have been included in the analysis.
A systematic review of symptomatic epidural POH after spine
surgery3 found an overall calculated incidence of 0.2%, with
individual study incidence ranging from 0% to 1.0%. So, the
occurrence of 1.1% in the current series was slightly higher than
the reported overall calculated incidence. This difference might
be because 2 patients with POH in the soft tissues that
nevertheless caused clinical deterioration were included in the
analysis. POH after spinal surgery usually presents early in the
postoperative period, but DPOSEH can be the cause of
neurologic deterioration after spinal surgery (symptoms appear
>3 days after the index procedure).24 So far, the incidence of
DPOSEH has been reported to vary between 0.05% and
0.17%24,26,28 and the longest duration until symptom onset has
been 13 days after the initial surgery.27 In our series, we detected a
surprisingly high incidence of DPOSEH (0.6%), whereas the
longest duration until recognition of POH and hematoma
removal was 11 and 13 days, respectively. So, this relatively
higher frequency of DPOSEH might also play a role in the
greater overall incidence of POH after spinal surgery in this series.
Rapid diagnosis of POH and earlier surgical intervention may
result in greater neurologic recovery.22,28,30 POH was recognized
and treated within 24 hours after 42.3% of craniotomies and 26.
6% of spinal procedures in this series. Previously, it has been
suggested that patients having elective supratentorial operations
can safely be transferred from the ICU to a neurosurgical ward for
observation, if they have regained their preoperative neurologic
status by 6 hours after surgery.8 Another older study showed no
clear relationship between the time of recognition of POH after
spinal surgery and the final clinical outcome,7 but newer studies
are needed to reevaluate the importance of POH onset on
prognosis.
POH Incidence After Different Types of Procedure
Our observations may indicate that POH is more often seen after
decompressive craniectomy, cranioplasty, bypass surgery, and
epidural hematoma removal. A recent retrospective multicenter
study also showed that primary craniotomy for hematoma evacu-
ation is associated with higher risk for rebleeding post-
operatively.18 In addition, according to the systematic review
published in 2011 and mentioned earlier, traumatic lesions are
intracranial diseases more prone to POH.2 In older studies, POH
was described after 3.7%e6.9% of craniotomies for traumatic
intracranial mass.4 Decompressive craniectomy, cranioplasty,
and epidural hematoma removal can all be partly related to
traumatic brain injury, and therefore, our findings support the
data on traumatic lesions reported so far. Concerning
craniectomies in this series, all patients had developed
malignant intracranial hypertension: 1 patient underwent the494 www.SCIENCEDIRECT.com WORLD NEUprocedure because of cerebellar infarction, 1 because of internal
carotid artery aneurysm rupture, and the remaining 5 patients all
had traumatic injuries. Decompressive craniectomy carries a
significant risk of rebleeding postoperatively (usually
contralateral to the craniectomy site) and our findings
(incidence of 7.9%) support the data reported so far.38-42 The
relatively high incidence of POH (3.6%) after cranioplasty in this
series is also in line with the rates from the literature; POH as a
complication occurs after up to 6.9% of cranioplasties.43-49
Regarding bypass surgery, it has also been reported previously
that ICH after vascular reconstruction surgery (as a result of
moyamoya disease) occurs in 2.8% of cases,50 which is
comparable to the detected rate of 1.7% in our series.
In contrast to concurring findings on traumatic lesions and
bypass surgery, there were no POH after AVM removals in the
present series, indicating that AVM by pathology itself might not
be prone to bleeding complication. A systematic review and meta-
analysis on AVMs has reported an overall POH rate of 1.4 per 100
person-years.51 According to that review, POH is uncommon after
microsurgical removal of AVMs (0.18 per 100 person-years). All
AVM removals are performed microsurgically in our institution,
and therefore, this technique might be 1 key component in
decreasing the risks of POH after AVM removal. Our observations
in neoplasm surgery differ also from previous findings. So far,
overall rates of POH after neoplasm surgery have ranged from
1.1% to 7.1%,1,5,8,52-56 which is higher than the rate detected in this
series (0.7%).
The incidence of POH after elective aneurysm surgery varies
between 0.1% and 2.6%.1,57-61 In our series, there was no POH
after elective aneurysm surgery and the reason for such a low rate
might be that in our center, elective aneurysm clippings were
performed mainly by 1 highly experienced senior surgeon micro-
neurosurgically. Although according to an older study,8 there was
no correlation between the rank of the surgeon and the occurrence
of POH after craniotomy, in a newer study, there was a lower rate
of surgical complications (15.8% vs. 28.6%) and surgical vascular
complications (7.6% vs. 16.7%) among high-volume (clipped >40
aneurysms per annum during the study period) compared with
low-volume surgeons (<40 aneurysms), but this was statistically
not significant.62 However, patients operated on by high-volume
surgeons were significantly less likely to have a new neurologic
deficit on discharge (17.1% vs. 33.3%; P ¼ 0.03), so experience
may play a role in such a low incidence of POH after unruptured
aneurysm clippings in this series.
POH Risk Factors
Earlier studies of POH after craniotomy have suggested an asso-
ciation with advanced age, preexisting, intraoperative, and post-
operative hypertension, coagulopathies (also caused by
preoperative medications), great intraoperative blood loss, blood
transfusion during or after the index operation, primary crani-
otomy for hematoma evacuation, specific types of tumors, and
postoperative ventilator dependence >48 hours as well as
unplanned reintubation.1,2,4-7,9-18,35,36 Although risk factors for
identifying patients at high risk of developing spinal epidural POH
have been suggested, because of the rare occurrence of this
complication, there are limited and inconsistent data about risk
factors for POH in spinal surgery. However, a multicenter caseROSURGERY, http://dx.doi.org/10.1016/j.wneu.2017.09.007
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than 10 units a week, multilevel procedure, and previous spinal
surgery are all associated with developing POH after spine
surgery. Of previously detected risk factors, hypertension
(preexisting, intraoperative, and postoperative) had the highest
occurrence in this sample. Although all our patients undergoing
craniotomy are kept until at least the next morning in the ICU,
where blood pressure is monitored routinely and a goal blood
pressure is set (160 mm Hg or lower, if indicated), a relatively
high percentage of patients (84.6%) presented with
postoperative hypertension after craniotomy, whereas not all of
them received antihypertensive medications in the ICU. On one
hand, this factor might support the previous findings about
possible risk factors,10,16,18 but on the other hand, we registered
any increase (except artifacts) in systolic blood pressure greater
than 160 mm Hg postoperatively, so this finding might also be
aggravated by our method. Further studies are needed to assess
whether even a short-term increase in systolic blood pressure,
which disappears spontaneously, should be aggressively treated
and what should be the exact target blood pressure to avoid
bleeding complications. However, special attention should be paid
to optimizing the patient’s antihypertensive treatment preopera-
tively and pain treatment postoperatively to keep the patient
normotensive.
Outcome and Complications After POH
The overall incidence of venous thromboembolism (VTE) in
patients undergoing craniotomy is 2.6%e3.5%,17,63-66 whereas in
neoplasm neurosurgery, the rates are remarkably higher, ranging
from 3% to 26%, even with DVT prophylaxis.55,56,67 In the current
series, the occurrence of VTE in neurosurgical patients with POH
was 5.7%, and in postcraniotomy patients with POH, it was 13.0%.
So far, there have been only a few data about neurosurgical
patients who have hemorrhagic and thromboembolic complica-
tions at the same time.65 Our findings show the heterogeneity and
complexity of neurosurgical patients prone to POH, albeit they areWORLD NEUROSURGERY 108: 491-497, DECEMBER 2017at risk of developing bleeding complications, they seem to be
predisposed to VTE. One possible explanation could be that
clinically significant POH leads to reoperation and often also to
prolonged ventilator dependence with bed rest, which all
independently are well-known VTE risk factors.56,63,64,67,68 It is
therefore challenging to start DVT prophylaxis in postcraniotomy
patients with a bleeding complication, but on the other hand, in
patients with a high risk for thrombosis, DVT prophylaxis is
nevertheless indicated, even if they have high bleeding risk or have
had a hemorrhagic complication. An individualized multidisci-
plinary approach in these patients might be the key component in
balancing the risks of bleeding and thrombosis.
The main limitation of this study is its retrospective design and
the rare occurrence of this complication. The results of a single-
center study also partly lack generalizability. Moreover, we
cannot suggest any definitive confounding factor, because this
study did not include comparison with a control population.
Therefore, we report only the cases that have been identified so
far, and the results should be interpreted with caution because of
low numbers of observed POH cases. Nevertheless, the findings of
this study are valuable in providing patients with information
regarding surgical risks and expected postsurgical management.CONCLUSIONS
POH requiring surgical removal was a rare complication with an
overall occurrence of 0.6% in this series (0.6% after craniotomies
and 1.1% after spine operations). Our observations may indicate
that POH is more often seen after decompressive craniectomy,
cranioplasty, bypass surgery, and epidural hematoma removal.
Elective aneurysm clipping, AVM removal, and epilepsy surgery
can be performed with minimal bleeding complications. Because
POH after craniotomy was related to high morbidity and mortality,
proper identification of risk factors and avoiding them, if possible,
might therefore decrease the incidence of POH and improve the
outcome of these patients.REFERENCES
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